1. Home
  2. CVEO vs CLLS Comparison

CVEO vs CLLS Comparison

Compare CVEO & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

N/A

Current Price

$33.36

Market Cap

383.3M

ML Signal

N/A

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$3.18

Market Cap

394.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVEO
CLLS
Founded
1977
1999
Country
United States
France
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.3M
394.4M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
CVEO
CLLS
Price
$33.36
$3.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$37.00
$8.33
AVG Volume (30 Days)
137.9K
15.5K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.72
N/A
Revenue Next Year
$5.61
$0.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.75
$2.35
52 Week High
$36.50
$5.48

Technical Indicators

Market Signals
Indicator
CVEO
CLLS
Relative Strength Index (RSI) 53.37 63.18
Support Level $32.46 $3.12
Resistance Level $35.74 $3.40
Average True Range (ATR) 1.58 0.15
MACD 0.08 0.05
Stochastic Oscillator 61.63 100.00

Price Performance

Historical Comparison
CVEO
CLLS

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: